Cristina Cruz Zambrano
Member of the Cancer profiling research line
Email: cristina.cruz@umedicina.cat
ORCID: 0000-0002-6474-7504
Scientific Profile: URECERCA
Cristina Cruz is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). Her research focuses on cancer biomarkers of prognosis and treatment response.
She graduated in Biochemistry in 1996 (University of Barcelona) and earned the doctorate in Biochemistry in 2001. In 2006 she graduated in Medicine (University of Barcelona) and is a Medical Oncology specialist since 2011. From 2011 to 2018 she was a clinical and translational investigator at Vall d’Hebron Institute of Oncology (VHIO). She participated in a number of clinical trials in the field of early drug development (Phase I) and Phase II & III clinical trials investigating targeted therapies for hereditary breast and ovarian cancers. As a postdoctoral researcher from VHIO’s Experimental Therapeutics Group, she also developed translational projects to investigate the determinants of treatment response and resistance among BRCA1/2 germline mutation carriers, including the functional biomarker RAD51. In 2019, she joined the Faculty of Medicine at UVic-UCC, where she teaches Human Genetics, Histology, Medical Embryology and Physiology.
My last happenings:
Exploiting Hormesis for Plasma-treated Hydrogel Therapeutic platforms (HormeTic)
Subprojects: Subproject 1: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for cancer treatment (HormOnc)". Subproject 2: "Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal)". Original Title (English): Exploiting Hormesis for plasma-treated hydrogel therapeutic platforms for Healing of complex cutaneous wounds (HormHeal). Objective: Innovating in the healing of complex wounds. TR2Lab research team members: Albert Espona-Noguera (Principal Investigator). Cristina Canal (PI1 of Subproject 1) & Francesco Tampieri (PI2 of Subproject 1). Members of TR2Lab who participate in this project: Elisabet Sarri, Laia Bosch, Gemma Sangüesa, Francesc Sant Masoliver, Cristina Martin Mancera, David Benito Guasch, Clara Masó [...]
Lactic acid as a marker of therapeutic response
Members: Dr M. Parera (CHV), Dr I. Barba (Medicina UVic) Financial support: APR-IRIS-CC The Project “Lactic acid as a marker of therapeutic response” has received approval from the IRIS-CC ethics committee and will start recruiting patients in earnest. The project is a collaboration between Consorci Hospitalari de Vic (Dr M. Parera) and the faculty of medicine UVic (Dr I.Barba) and will evaluate lactic acid as a potential marker of therapeutic response in non-small cell lung cancer patients. We would like to thank all the patients who selflessly participate in this project. El projecte «L'àcid làctic com a [...]
Predictors of Recurrence and Survival in Endometrial Cancer: A 22-Year Single-Center Cohort Study
Funding: Industrial Doctorates Plan of the Government of Catalonia (Industrial Doctorate; DI-2024-00104) Osona Contra el Càncer (OCC) «Ajuts per a Projectes de Recerca Interns» call of the Fundació d’Estudis Superiors en Ciències de la Salut (FESS; APR-2025-FESS) Authors: E. Sardo (1,6,7,8,), M. Alejo Sánchez (2,7), M. Parera Roig (1,6,7,8,), C. Cruz Zambrano (6,7,8,), N. Espejo Herrera (2,8), K. Salas León (2), A. Canet Gómez (2), M. Armengou Ríos (2), C. Vila Díaz (2), E. Puigoriol Juvanteny (3), S. Moros Weakner (4), V. Álvarez Torrecillas (4), I. Gallego Anton (8), M.Panadès Tejero (8), M. Zarcero Estevez (5), S. Griñó [...]
